Su B, Pei R J, Yeh K T, Hsu Y H, Lai Y S
Department of Pathology, School of Medicine, China Medical College, Taichung, Taiwan.
Pathobiology. 1994;62(3):155-9. doi: 10.1159/000163897.
The stability of cytokeratin during tumor transformation in hepatocellular carcinoma was studied. We applied biochemical methodology to look into the switching of cytokeratin molecules in tumor transformation. First, by centrifugation the cytokeratin molecules were extracted from both liver and hepatoma tissues. The extracts were then soaked with cyanogen bromide-activated Sepharose 4B beads previously coated by monoclonal anti-cytokeratin antibody. The bound molecules were then released from the resin with salt. Second, the isolated molecules of both were treated with lysosomal enzyme and analyzed on two-dimensional gels. The results demonstrated that there was a modulation in cytokeratin molecules, and the hepatoma cytokeratin was generated from the hepatocyte cytokeratin.
研究了细胞角蛋白在肝细胞癌肿瘤转化过程中的稳定性。我们应用生化方法来研究肿瘤转化过程中细胞角蛋白分子的转换。首先,通过离心从肝脏和肝癌组织中提取细胞角蛋白分子。然后将提取物与先前用单克隆抗细胞角蛋白抗体包被的溴化氰活化的琼脂糖4B珠浸泡。然后用盐从树脂中释放结合的分子。其次,将两者分离出的分子用溶酶体酶处理,并在二维凝胶上进行分析。结果表明细胞角蛋白分子存在调节,肝癌细胞角蛋白由肝细胞角蛋白产生。